+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Diagnostic Radiopharmaceuticals Market - Global Forecast 2026-2032- Product Image
Diagnostic Radiopharmaceuticals Market - Global Forecast 2026-2032- Product Image
Sale

Diagnostic Radiopharmaceuticals Market - Global Forecast 2026-2032

  • Report

  • 190 Pages
  • September 2026
  • Region: Global
  • 360iResearch™
  • ID: 6084863
UP TO OFF until Jan 01st 2027
1h Free Analyst Time
Description Jump to:
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.
The Diagnostic Radiopharmaceuticals Market is projected to reach USD 3.59 Billion in 2026. It is expected to continue growing at a CAGR of 10.33%, reaching USD 6.49 Billion by 2032.

Diagnostic Radiopharmaceuticals: Executive Overview

Diagnostic radiopharmaceuticals combine a radioactive isotope with a targeting molecule to visualize physiological processes, support disease characterization, and guide clinical decisions. Their use spans oncology, cardiology, neurology, and other specialties, with adoption shaped by diagnostic value, clinical workflows, isotope availability, regulation, reimbursement, and imaging infrastructure.

How Molecular Imaging Is Reshaping Diagnostic Practice

The field is shifting from primarily anatomical assessment toward molecular and functional imaging. Greater emphasis on earlier disease characterization, treatment selection, response assessment, and integrated diagnostic pathways is increasing the importance of radiopharmaceuticals within multidisciplinary care. Progress also depends on reliable isotope production, validated radiochemistry, specialized handling, scanner access, and coordinated logistics because many products have short usable lifetimes.

Artificial Intelligence Strengthens Interpretation and Workflow

Artificial intelligence is being applied to image reconstruction, attenuation correction, lesion detection, segmentation, quantification, and workflow prioritization. These tools can improve consistency and help clinicians process complex multimodal data, but their value depends on representative training data, external validation, interoperability, cybersecurity, and transparent clinical oversight. AI should augment-not replace-radiologist and nuclear medicine expertise, particularly where findings require clinical context.

Regional Insights: Infrastructure, Access, and Supply Resilience

North America benefits from advanced imaging capacity, specialized clinical expertise, and established radiopharmacy networks, while access remains influenced by reimbursement and geographic concentration. Europe combines strong academic and regulatory capabilities with cross-border coordination challenges and uneven availability among health systems. Asia-Pacific is characterized by expanding imaging infrastructure, rising clinical capability, and substantial variation between mature and developing markets. Latin America continues to prioritize access, isotope logistics, and workforce development. The Middle East is investing in advanced healthcare capacity and centralized specialist services, while Africa faces greater constraints in isotope supply, equipment, trained personnel, and referral networks.

Group Insights: Cooperation and Regulatory Alignment

ASEAN countries share opportunities to improve regional training, procurement coordination, and radiopharmaceutical logistics, although healthcare capacity differs considerably. BRICS members represent diverse research, manufacturing, and clinical environments, making regulatory cooperation and resilient supply chains important priorities. The European Union benefits from shared scientific and regulatory frameworks but must manage national differences in reimbursement and service delivery. G7 systems generally possess mature research and imaging ecosystems, with attention increasingly focused on productivity, workforce constraints, and equitable access. GCC countries are strengthening specialized healthcare infrastructure, while NATO members can benefit from coordinated resilience planning for critical medical supply chains.

Country Insights: Distinct Capabilities and Access Priorities

Australia combines advanced clinical services with geographic distribution challenges. Brazil is focused on expanding specialized access across a large and diverse health system. Canada has strong expertise but must address distance, infrastructure, and equitable provincial access. China is developing domestic capabilities across imaging, isotope production, and clinical research. France, Germany, Italy, Spain, and the United Kingdom have established nuclear medicine communities, with priorities including workforce capacity, reimbursement sustainability, and timely access. India is expanding diagnostic infrastructure while managing substantial regional variation. Japan and South Korea pair advanced healthcare technology with aging-population needs and process optimization. Mexico is working to broaden specialized imaging capacity and referral access. Russia’s priorities include domestic resilience, infrastructure, and continuity of specialized services. The United States has extensive clinical and research capabilities, with ongoing attention to supply reliability, reimbursement, and access across urban and rural settings.

Priority Actions for Diagnostic Radiopharmaceutical Leaders

Industry leaders should strengthen end-to-end supply resilience through diversified isotope sourcing, validated contingency plans, and close coordination with radiopharmacies and healthcare providers. Clinical development should prioritize evidence that connects imaging findings with meaningful management decisions, while regulatory and reimbursement strategies should be adapted to local requirements. Investment in workforce training, standardized quality systems, interoperable data, and AI governance can support safe adoption. Leaders should also design access strategies around referral pathways, mobile or hub-and-spoke services where appropriate, and partnerships that improve availability beyond major academic centers.

Research Methodology for a Market-Structure Assessment

This executive summary uses a structured qualitative assessment of diagnostic radiopharmaceuticals, considering clinical applications, isotope and radiochemistry requirements, imaging infrastructure, regulation, reimbursement, logistics, workforce capability, and digital transformation. Regional, group, and country perspectives are synthesized from established healthcare-system characteristics and technology-adoption factors. Interpretations are bounded by the available market definition and avoid unsupported quantitative claims, company-specific analysis, and numerical market projections.

Conclusion: Building Reliable, Clinically Integrated Molecular Imaging

Diagnostic radiopharmaceuticals are becoming more closely integrated with precision diagnosis and treatment planning. Sustainable progress will depend not only on scientific innovation but also on dependable isotope supply, qualified personnel, appropriate imaging capacity, evidence-based reimbursement, and responsible use of AI. Organizations that align clinical utility with operational resilience and equitable access will be better positioned to support the next stage of molecular imaging adoption.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Definition
1.3. Market Segmentation & Coverage
1.4. Years Considered for the Study
1.5. Currency Considered for the Study
1.6. Language Considered for the Study
1.7. Key Stakeholders
2. Research Methodology
2.1. Introduction
2.2. Research Design
2.2.1. Primary Research
2.2.2. Secondary Research
2.3. Research Framework
2.3.1. Qualitative Analysis
2.3.2. Quantitative Analysis
2.4. Market Size Estimation
2.4.1. Top-Down Approach
2.4.2. Bottom-Up Approach
2.5. Data Triangulation
2.6. Research Outcomes
2.7. Research Assumptions
2.8. Research Limitations
3. Executive Summary
3.1. Introduction
3.2. CXO Perspective
3.3. New Revenue Opportunities
3.4. Next-Generation Business Models
3.5. Industry Roadmap
4. Market Overview
4.1. Introduction
4.2. Industry Ecosystem & Value Chain Analysis
4.2.1. Supply-Side Analysis
4.2.2. Demand-Side Analysis
4.2.3. Stakeholder Analysis
4.3. Market Dynamics
4.3.1. Key Drivers
4.3.2. Key Restraints
4.3.3. Key Opportunities
4.3.4. Key Challenges
4.4. Porter’s Five Forces Analysis
4.5. PESTLE Analysis
4.6. Market Outlook
4.6.1. Near-Term Market Outlook (0-2 Years)
4.6.2. Medium-Term Market Outlook (3-5 Years)
4.6.3. Long-Term Market Outlook (5-10 Years)
4.7. Go-to-Market Strategy
5. Market Insights
5.1. Consumer Insights & End-User Perspective
5.2. Consumer Experience Benchmarking
5.3. Opportunity Mapping
5.4. Distribution Channel Analysis
5.5. Pricing Trend Analysis
5.6. Regulatory Compliance & Standards Framework
5.7. ESG & Sustainability Analysis
5.8. Disruption & Risk Scenarios
5.9. Return on Investment & Cost-Benefit Analysis
6. Cumulative Impact of Artificial Intelligence 2026
7. Diagnostic Radiopharmaceuticals Market, by Imaging Modality
7.1. Introduction
7.2. PET Radiopharmaceuticals
7.3. SPECT Radiopharmaceuticals
8. Diagnostic Radiopharmaceuticals Market, by Radionuclide
8.1. Introduction
8.2. Oxygen-15
8.3. Nitrogen-13
8.4. Rubidium-82
8.5. Fluorine-18
8.6. Gallium-68
8.7. Technetium-99m
8.8. Iodine-123
8.9. Copper-64
8.10. Indium-111
8.11. Zirconium-89
8.12. Iodine-124
8.13. Thallium-201
9. Diagnostic Radiopharmaceuticals Market, by Application
9.1. Introduction
9.2. Cardiology
9.3. Neurology
9.4. Oncology
9.5. Endocrinology
9.6. Nephrology
9.7. Infection Inflammation
9.8. Pulmonology
9.9. Gastroenterology
9.10. Orthopedics
10. Diagnostic Radiopharmaceuticals Market, by End Use
10.1. Introduction
10.2. Hospitals
10.3. Diagnostic Imaging Centers
10.4. Research Institutes
10.5. Specialty Clinics
11. Diagnostic Radiopharmaceuticals Market, by Region
11.1. Introduction
11.2. Asia-Pacific
11.3. Europe
11.4. North America
11.5. Latin America
11.6. Africa
11.7. Middle East
12. Diagnostic Radiopharmaceuticals Market, by Group
12.1. Introduction
12.2. NATO
12.3. G7
12.4. European Union
12.5. BRICS
12.6. ASEAN
12.7. GCC
13. Diagnostic Radiopharmaceuticals Market, by Country
13.1. Introduction
13.2. United States
13.3. China
13.4. Germany
13.5. Japan
13.6. India
13.7. United Kingdom
13.8. Canada
13.9. France
13.10. Brazil
13.11. Mexico
13.12. Italy
13.13. Australia
13.14. South Korea
13.15. Russia
13.16. Spain
14. Competitive Landscape
14.1. Market Share Analysis, 2025
14.2. Market Concentration Analysis, 2025
14.2.1. Concentration Ratio (CR)
14.2.2. Herfindahl Hirschman Index (HHI)
14.3. Recent Developments & Impact Analysis, 2025
14.4. Product Portfolio Analysis, 2025
14.5. Benchmarking Analysis, 2025
15. Company Profiles
15.1. Curium MidCo S.à r.l.
15.2. Lantheus Holdings, Inc.
15.3. GE HealthCare Technologies Inc.
15.4. Telix Pharmaceuticals Limited
15.5. Cardinal Health, Inc.
15.6. Siemens Healthineers AG
15.7. Jubilant Pharmova Limited
15.8. Bracco Imaging S.p.A.
15.9. China Isotope & Radiation Corporation
15.10. Novartis AG
15.11. ABX advanced biochemical compounds GmbH
15.12. AtomVie Global Radiopharma Inc.
15.13. Australian Nuclear Science and Technology Organisation
15.14. BWXT Medical Ltd.
15.15. Clarity Pharmaceuticals Ltd
15.16. Curasight A/S
15.17. Cyclopharm Limited
15.18. Cyclotek (Aust) Pty Ltd
15.19. DuChemBIO Co., Ltd.
15.20. Eckert & Ziegler SE
15.21. Eli Lilly and Company
15.22. FutureChem Co., Ltd.
15.23. Global Medical Solutions, Ltd.
15.24. Institute of Isotopes Co., Ltd.
15.25. IRE ELiT S.A.
15.26. Isologic Innovative Radiopharmaceuticals Inc.
15.27. ITM Isotope Technologies Munich SE
15.28. NorthStar Medical Radioisotopes, LLC
15.29. NTP Radioisotopes SOC Ltd
15.30. Nucleus RadioPharma, Inc.
15.31. Nusano, Inc.
15.32. PDRadiopharma Inc.
15.33. PharmaLogic Holdings Corp.
15.34. RadioMedix, Inc.
15.35. Radiopharm Theranostics Limited
15.36. ROTOP Pharmaka GmbH
15.37. SHINE Technologies, LLC
15.38. SOFIE Co.
15.39. SpectronRx, Inc.
15.40. Yantai Dongcheng Pharmaceutical Group Co., Ltd.
16. Key Experts
LIST OF FIGURES
FIGURE 1. Global Diagnostic Radiopharmaceuticals Market, Years Considered for the Study
FIGURE 2. Global Diagnostic Radiopharmaceuticals Market, Research Design
FIGURE 3. Global Diagnostic Radiopharmaceuticals Market, Research Framework
FIGURE 4. Global Diagnostic Radiopharmaceuticals Market, Data Triangulation
FIGURE 5. Global Diagnostic Radiopharmaceuticals Market Size, 2017-2032 (USD Million)
FIGURE 6. Global Diagnostic Radiopharmaceuticals Market Size, by Imaging Modality, 2025 vs 2032 (%)
FIGURE 7. Global Diagnostic Radiopharmaceuticals Market Size, by Imaging Modality, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 8. Global Diagnostic Radiopharmaceuticals Market Size, by Radionuclide, 2025 vs 2032 (%)
FIGURE 9. Global Diagnostic Radiopharmaceuticals Market Size, by Radionuclide, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 10. Global Diagnostic Radiopharmaceuticals Market Size, by Application, 2025 vs 2032 (%)
FIGURE 11. Global Diagnostic Radiopharmaceuticals Market Size, by Application, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 12. Global Diagnostic Radiopharmaceuticals Market Size, by End Use, 2025 vs 2032 (%)
FIGURE 13. Global Diagnostic Radiopharmaceuticals Market Size, by End Use, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 14. Global Diagnostic Radiopharmaceuticals Market Size, by Region, 2025 vs 2032 (%)
FIGURE 15. Global Diagnostic Radiopharmaceuticals Market Size, by Region, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 16. Global Diagnostic Radiopharmaceuticals Market Size, by Group, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 17. Global Diagnostic Radiopharmaceuticals Market Size, by Country, 2025 vs 2032 (%)
FIGURE 18. Global Diagnostic Radiopharmaceuticals Market Size, by Country, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 19. Global Diagnostic Radiopharmaceuticals Market Share, by Key Player, 2025
LIST OF TABLES
TABLE 1. Global Diagnostic Radiopharmaceuticals Market Segmentation & Coverage
TABLE 2. Global Diagnostic Radiopharmaceuticals Market Size, 2017-2032 (USD Million)
TABLE 3. Global Diagnostic Radiopharmaceuticals Market Size, by Imaging Modality, 2017-2032 (USD Million)
TABLE 4. Global PET Radiopharmaceuticals Market Size, by Region, 2017-2032 (USD Million)
TABLE 5. Global PET Radiopharmaceuticals Market Size, by Group, 2017-2032 (USD Million)
TABLE 6. Global PET Radiopharmaceuticals Market Size, by Country, 2017-2032 (USD Million)
TABLE 7. Global SPECT Radiopharmaceuticals Market Size, by Region, 2017-2032 (USD Million)
TABLE 8. Global SPECT Radiopharmaceuticals Market Size, by Group, 2017-2032 (USD Million)
TABLE 9. Global SPECT Radiopharmaceuticals Market Size, by Country, 2017-2032 (USD Million)
TABLE 10. Global Diagnostic Radiopharmaceuticals Market Size, by Radionuclide, 2017-2032 (USD Million)
TABLE 11. Global Oxygen-15 Market Size, by Region, 2017-2032 (USD Million)
TABLE 12. Global Oxygen-15 Market Size, by Group, 2017-2032 (USD Million)
TABLE 13. Global Oxygen-15 Market Size, by Country, 2017-2032 (USD Million)
TABLE 14. Global Nitrogen-13 Market Size, by Region, 2017-2032 (USD Million)
TABLE 15. Global Nitrogen-13 Market Size, by Group, 2017-2032 (USD Million)
TABLE 16. Global Nitrogen-13 Market Size, by Country, 2017-2032 (USD Million)
TABLE 17. Global Rubidium-82 Market Size, by Region, 2017-2032 (USD Million)
TABLE 18. Global Rubidium-82 Market Size, by Group, 2017-2032 (USD Million)
TABLE 19. Global Rubidium-82 Market Size, by Country, 2017-2032 (USD Million)
TABLE 20. Global Fluorine-18 Market Size, by Region, 2017-2032 (USD Million)
TABLE 21. Global Fluorine-18 Market Size, by Group, 2017-2032 (USD Million)
TABLE 22. Global Fluorine-18 Market Size, by Country, 2017-2032 (USD Million)
TABLE 23. Global Gallium-68 Market Size, by Region, 2017-2032 (USD Million)
TABLE 24. Global Gallium-68 Market Size, by Group, 2017-2032 (USD Million)
TABLE 25. Global Gallium-68 Market Size, by Country, 2017-2032 (USD Million)
TABLE 26. Global Technetium-99m Market Size, by Region, 2017-2032 (USD Million)
TABLE 27. Global Technetium-99m Market Size, by Group, 2017-2032 (USD Million)
TABLE 28. Global Technetium-99m Market Size, by Country, 2017-2032 (USD Million)
TABLE 29. Global Iodine-123 Market Size, by Region, 2017-2032 (USD Million)
TABLE 30. Global Iodine-123 Market Size, by Group, 2017-2032 (USD Million)
TABLE 31. Global Iodine-123 Market Size, by Country, 2017-2032 (USD Million)
TABLE 32. Global Copper-64 Market Size, by Region, 2017-2032 (USD Million)
TABLE 33. Global Copper-64 Market Size, by Group, 2017-2032 (USD Million)
TABLE 34. Global Copper-64 Market Size, by Country, 2017-2032 (USD Million)
TABLE 35. Global Indium-111 Market Size, by Region, 2017-2032 (USD Million)
TABLE 36. Global Indium-111 Market Size, by Group, 2017-2032 (USD Million)
TABLE 37. Global Indium-111 Market Size, by Country, 2017-2032 (USD Million)
TABLE 38. Global Zirconium-89 Market Size, by Region, 2017-2032 (USD Million)
TABLE 39. Global Zirconium-89 Market Size, by Group, 2017-2032 (USD Million)
TABLE 40. Global Zirconium-89 Market Size, by Country, 2017-2032 (USD Million)
TABLE 41. Global Iodine-124 Market Size, by Region, 2017-2032 (USD Million)
TABLE 42. Global Iodine-124 Market Size, by Group, 2017-2032 (USD Million)
TABLE 43. Global Iodine-124 Market Size, by Country, 2017-2032 (USD Million)
TABLE 44. Global Thallium-201 Market Size, by Region, 2017-2032 (USD Million)
TABLE 45. Global Thallium-201 Market Size, by Group, 2017-2032 (USD Million)
TABLE 46. Global Thallium-201 Market Size, by Country, 2017-2032 (USD Million)
TABLE 47. Global Diagnostic Radiopharmaceuticals Market Size, by Application, 2017-2032 (USD Million)
TABLE 48. Global Cardiology Market Size, by Region, 2017-2032 (USD Million)
TABLE 49. Global Cardiology Market Size, by Group, 2017-2032 (USD Million)
TABLE 50. Global Cardiology Market Size, by Country, 2017-2032 (USD Million)
TABLE 51. Global Neurology Market Size, by Region, 2017-2032 (USD Million)
TABLE 52. Global Neurology Market Size, by Group, 2017-2032 (USD Million)
TABLE 53. Global Neurology Market Size, by Country, 2017-2032 (USD Million)
TABLE 54. Global Oncology Market Size, by Region, 2017-2032 (USD Million)
TABLE 55. Global Oncology Market Size, by Group, 2017-2032 (USD Million)
TABLE 56. Global Oncology Market Size, by Country, 2017-2032 (USD Million)
TABLE 57. Global Endocrinology Market Size, by Region, 2017-2032 (USD Million)
TABLE 58. Global Endocrinology Market Size, by Group, 2017-2032 (USD Million)
TABLE 59. Global Endocrinology Market Size, by Country, 2017-2032 (USD Million)
TABLE 60. Global Nephrology Market Size, by Region, 2017-2032 (USD Million)
TABLE 61. Global Nephrology Market Size, by Group, 2017-2032 (USD Million)
TABLE 62. Global Nephrology Market Size, by Country, 2017-2032 (USD Million)
TABLE 63. Global Infection Inflammation Market Size, by Region, 2017-2032 (USD Million)
TABLE 64. Global Infection Inflammation Market Size, by Group, 2017-2032 (USD Million)
TABLE 65. Global Infection Inflammation Market Size, by Country, 2017-2032 (USD Million)
TABLE 66. Global Pulmonology Market Size, by Region, 2017-2032 (USD Million)
TABLE 67. Global Pulmonology Market Size, by Group, 2017-2032 (USD Million)
TABLE 68. Global Pulmonology Market Size, by Country, 2017-2032 (USD Million)
TABLE 69. Global Gastroenterology Market Size, by Region, 2017-2032 (USD Million)
TABLE 70. Global Gastroenterology Market Size, by Group, 2017-2032 (USD Million)
TABLE 71. Global Gastroenterology Market Size, by Country, 2017-2032 (USD Million)
TABLE 72. Global Orthopedics Market Size, by Region, 2017-2032 (USD Million)
TABLE 73. Global Orthopedics Market Size, by Group, 2017-2032 (USD Million)
TABLE 74. Global Orthopedics Market Size, by Country, 2017-2032 (USD Million)
TABLE 75. Global Diagnostic Radiopharmaceuticals Market Size, by End Use, 2017-2032 (USD Million)
TABLE 76. Global Hospitals Market Size, by Region, 2017-2032 (USD Million)
TABLE 77. Global Hospitals Market Size, by Group, 2017-2032 (USD Million)
TABLE 78. Global Hospitals Market Size, by Country, 2017-2032 (USD Million)
TABLE 79. Global Diagnostic Imaging Centers Market Size, by Region, 2017-2032 (USD Million)
TABLE 80. Global Diagnostic Imaging Centers Market Size, by Group, 2017-2032 (USD Million)
TABLE 81. Global Diagnostic Imaging Centers Market Size, by Country, 2017-2032 (USD Million)
TABLE 82. Global Research Institutes Market Size, by Region, 2017-2032 (USD Million)
TABLE 83. Global Research Institutes Market Size, by Group, 2017-2032 (USD Million)
TABLE 84. Global Research Institutes Market Size, by Country, 2017-2032 (USD Million)
TABLE 85. Global Specialty Clinics Market Size, by Region, 2017-2032 (USD Million)
TABLE 86. Global Specialty Clinics Market Size, by Group, 2017-2032 (USD Million)
TABLE 87. Global Specialty Clinics Market Size, by Country, 2017-2032 (USD Million)
TABLE 88. Global Diagnostic Radiopharmaceuticals Market Size, by Region, 2017-2032 (USD Million)
TABLE 89. Asia-Pacific Diagnostic Radiopharmaceuticals Market Size, by Region, 2017-2032 (USD Million)
TABLE 90. Asia-Pacific Diagnostic Radiopharmaceuticals Market Size, by Imaging Modality, 2017-2032 (USD Million)
TABLE 91. Asia-Pacific Diagnostic Radiopharmaceuticals Market Size, by Radionuclide, 2017-2032 (USD Million)
TABLE 92. Asia-Pacific Diagnostic Radiopharmaceuticals Market Size, by Application, 2017-2032 (USD Million)
TABLE 93. Asia-Pacific Diagnostic Radiopharmaceuticals Market Size, by End Use, 2017-2032 (USD Million)
TABLE 94. Europe Diagnostic Radiopharmaceuticals Market Size, by Region, 2017-2032 (USD Million)
TABLE 95. Europe Diagnostic Radiopharmaceuticals Market Size, by Imaging Modality, 2017-2032 (USD Million)
TABLE 96. Europe Diagnostic Radiopharmaceuticals Market Size, by Radionuclide, 2017-2032 (USD Million)
TABLE 97. Europe Diagnostic Radiopharmaceuticals Market Size, by Application, 2017-2032 (USD Million)
TABLE 98. Europe Diagnostic Radiopharmaceuticals Market Size, by End Use, 2017-2032 (USD Million)
TABLE 99. North America Diagnostic Radiopharmaceuticals Market Size, by Region, 2017-2032 (USD Million)
TABLE 100. North America Diagnostic Radiopharmaceuticals Market Size, by Imaging Modality, 2017-2032 (USD Million)
TABLE 101. North America Diagnostic Radiopharmaceuticals Market Size, by Radionuclide, 2017-2032 (USD Million)
TABLE 102. North America Diagnostic Radiopharmaceuticals Market Size, by Application, 2017-2032 (USD Million)
TABLE 103. North America Diagnostic Radiopharmaceuticals Market Size, by End Use, 2017-2032 (USD Million)
TABLE 104. Latin America Diagnostic Radiopharmaceuticals Market Size, by Region, 2017-2032 (USD Million)
TABLE 105. Latin America Diagnostic Radiopharmaceuticals Market Size, by Imaging Modality, 2017-2032 (USD Million)
TABLE 106. Latin America Diagnostic Radiopharmaceuticals Market Size, by Radionuclide, 2017-2032 (USD Million)
TABLE 107. Latin America Diagnostic Radiopharmaceuticals Market Size, by Application, 2017-2032 (USD Million)
TABLE 108. Latin America Diagnostic Radiopharmaceuticals Market Size, by End Use, 2017-2032 (USD Million)
TABLE 109. Africa Diagnostic Radiopharmaceuticals Market Size, by Region, 2017-2032 (USD Million)
TABLE 110. Africa Diagnostic Radiopharmaceuticals Market Size, by Imaging Modality, 2017-2032 (USD Million)
TABLE 111. Africa Diagnostic Radiopharmaceuticals Market Size, by Radionuclide, 2017-2032 (USD Million)
TABLE 112. Africa Diagnostic Radiopharmaceuticals Market Size, by Application, 2017-2032 (USD Million)
TABLE 113. Africa Diagnostic Radiopharmaceuticals Market Size, by End Use, 2017-2032 (USD Million)
TABLE 114. Middle East Diagnostic Radiopharmaceuticals Market Size, by Region, 2017-2032 (USD Million)
TABLE 115. Middle East Diagnostic Radiopharmaceuticals Market Size, by Imaging Modality, 2017-2032 (USD Million)
TABLE 116. Middle East Diagnostic Radiopharmaceuticals Market Size, by Radionuclide, 2017-2032 (USD Million)
TABLE 117. Middle East Diagnostic Radiopharmaceuticals Market Size, by Application, 2017-2032 (USD Million)
TABLE 118. Middle East Diagnostic Radiopharmaceuticals Market Size, by End Use, 2017-2032 (USD Million)
TABLE 119. Global Diagnostic Radiopharmaceuticals Market Size, by Group, 2017-2032 (USD Million)
TABLE 120. NATO Diagnostic Radiopharmaceuticals Market Size, by Group, 2017-2032 (USD Million)
TABLE 121. NATO Diagnostic Radiopharmaceuticals Market Size, by Imaging Modality, 2017-2032 (USD Million)
TABLE 122. NATO Diagnostic Radiopharmaceuticals Market Size, by Radionuclide, 2017-2032 (USD Million)
TABLE 123. NATO Diagnostic Radiopharmaceuticals Market Size, by Application, 2017-2032 (USD Million)
TABLE 124. NATO Diagnostic Radiopharmaceuticals Market Size, by End Use, 2017-2032 (USD Million)
TABLE 125. G7 Diagnostic Radiopharmaceuticals Market Size, by Group, 2017-2032 (USD Million)
TABLE 126. G7 Diagnostic Radiopharmaceuticals Market Size, by Imaging Modality, 2017-2032 (USD Million)
TABLE 127. G7 Diagnostic Radiopharmaceuticals Market Size, by Radionuclide, 2017-2032 (USD Million)
TABLE 128. G7 Diagnostic Radiopharmaceuticals Market Size, by Application, 2017-2032 (USD Million)
TABLE 129. G7 Diagnostic Radiopharmaceuticals Market Size, by End Use, 2017-2032 (USD Million)
TABLE 130. European Union Diagnostic Radiopharmaceuticals Market Size, by Group, 2017-2032 (USD Million)
TABLE 131. European Union Diagnostic Radiopharmaceuticals Market Size, by Imaging Modality, 2017-2032 (USD Million)
TABLE 132. European Union Diagnostic Radiopharmaceuticals Market Size, by Radionuclide, 2017-2032 (USD Million)
TABLE 133. European Union Diagnostic Radiopharmaceuticals Market Size, by Application, 2017-2032 (USD Million)
TABLE 134. European Union Diagnostic Radiopharmaceuticals Market Size, by End Use, 2017-2032 (USD Million)
TABLE 135. BRICS Diagnostic Radiopharmaceuticals Market Size, by Group, 2017-2032 (USD Million)
TABLE 136. BRICS Diagnostic Radiopharmaceuticals Market Size, by Imaging Modality, 2017-2032 (USD Million)
TABLE 137. BRICS Diagnostic Radiopharmaceuticals Market Size, by Radionuclide, 2017-2032 (USD Million)
TABLE 138. BRICS Diagnostic Radiopharmaceuticals Market Size, by Application, 2017-2032 (USD Million)
TABLE 139. BRICS Diagnostic Radiopharmaceuticals Market Size, by End Use, 2017-2032 (USD Million)
TABLE 140. ASEAN Diagnostic Radiopharmaceuticals Market Size, by Group, 2017-2032 (USD Million)
TABLE 141. ASEAN Diagnostic Radiopharmaceuticals Market Size, by Imaging Modality, 2017-2032 (USD Million)
TABLE 142. ASEAN Diagnostic Radiopharmaceuticals Market Size, by Radionuclide, 2017-2032 (USD Million)
TABLE 143. ASEAN Diagnostic Radiopharmaceuticals Market Size, by Application, 2017-2032 (USD Million)
TABLE 144. ASEAN Diagnostic Radiopharmaceuticals Market Size, by End Use, 2017-2032 (USD Million)
TABLE 145. GCC Diagnostic Radiopharmaceuticals Market Size, by Group, 2017-2032 (USD Million)
TABLE 146. GCC Diagnostic Radiopharmaceuticals Market Size, by Imaging Modality, 2017-2032 (USD Million)
TABLE 147. GCC Diagnostic Radiopharmaceuticals Market Size, by Radionuclide, 2017-2032 (USD Million)
TABLE 148. GCC Diagnostic Radiopharmaceuticals Market Size, by Application, 2017-2032 (USD Million)
TABLE 149. GCC Diagnostic Radiopharmaceuticals Market Size, by End Use, 2017-2032 (USD Million)
TABLE 150. Global Diagnostic Radiopharmaceuticals Market Size, by Country, 2017-2032 (USD Million)
TABLE 151. United States Diagnostic Radiopharmaceuticals Market Size, 2017-2032 (USD Million)
TABLE 152. United States Diagnostic Radiopharmaceuticals Market Size, by Imaging Modality, 2017-2032 (USD Million)
TABLE 153. United States Diagnostic Radiopharmaceuticals Market Size, by Radionuclide, 2017-2032 (USD Million)
TABLE 154. United States Diagnostic Radiopharmaceuticals Market Size, by Application, 2017-2032 (USD Million)
TABLE 155. United States Diagnostic Radiopharmaceuticals Market Size, by End Use, 2017-2032 (USD Million)
TABLE 156. China Diagnostic Radiopharmaceuticals Market Size, 2017-2032 (USD Million)
TABLE 157. China Diagnostic Radiopharmaceuticals Market Size, by Imaging Modality, 2017-2032 (USD Million)
TABLE 158. China Diagnostic Radiopharmaceuticals Market Size, by Radionuclide, 2017-2032 (USD Million)
TABLE 159. China Diagnostic Radiopharmaceuticals Market Size, by Application, 2017-2032 (USD Million)
TABLE 160. China Diagnostic Radiopharmaceuticals Market Size, by End Use, 2017-2032 (USD Million)
TABLE 161. Germany Diagnostic Radiopharmaceuticals Market Size, 2017-2032 (USD Million)
TABLE 162. Germany Diagnostic Radiopharmaceuticals Market Size, by Imaging Modality, 2017-2032 (USD Million)
TABLE 163. Germany Diagnostic Radiopharmaceuticals Market Size, by Radionuclide, 2017-2032 (USD Million)
TABLE 164. Germany Diagnostic Radiopharmaceuticals Market Size, by Application, 2017-2032 (USD Million)
TABLE 165. Germany Diagnostic Radiopharmaceuticals Market Size, by End Use, 2017-2032 (USD Million)
TABLE 166. Japan Diagnostic Radiopharmaceuticals Market Size, 2017-2032 (USD Million)
TABLE 167. Japan Diagnostic Radiopharmaceuticals Market Size, by Imaging Modality, 2017-2032 (USD Million)
TABLE 168. Japan Diagnostic Radiopharmaceuticals Market Size, by Radionuclide, 2017-2032 (USD Million)
TABLE 169. Japan Diagnostic Radiopharmaceuticals Market Size, by Application, 2017-2032 (USD Million)
TABLE 170. Japan Diagnostic Radiopharmaceuticals Market Size, by End Use, 2017-2032 (USD Million)
TABLE 171. India Diagnostic Radiopharmaceuticals Market Size, 2017-2032 (USD Million)
TABLE 172. India Diagnostic Radiopharmaceuticals Market Size, by Imaging Modality, 2017-2032 (USD Million)
TABLE 173. India Diagnostic Radiopharmaceuticals Market Size, by Radionuclide, 2017-2032 (USD Million)
TABLE 174. India Diagnostic Radiopharmaceuticals Market Size, by Application, 2017-2032 (USD Million)
TABLE 175. India Diagnostic Radiopharmaceuticals Market Size, by End Use, 2017-2032 (USD Million)
TABLE 176. United Kingdom Diagnostic Radiopharmaceuticals Market Size, 2017-2032 (USD Million)
TABLE 177. United Kingdom Diagnostic Radiopharmaceuticals Market Size, by Imaging Modality, 2017-2032 (USD Million)
TABLE 178. United Kingdom Diagnostic Radiopharmaceuticals Market Size, by Radionuclide, 2017-2032 (USD Million)
TABLE 179. United Kingdom Diagnostic Radiopharmaceuticals Market Size, by Application, 2017-2032 (USD Million)
TABLE 180. United Kingdom Diagnostic Radiopharmaceuticals Market Size, by End Use, 2017-2032 (USD Million)
TABLE 181. Canada Diagnostic Radiopharmaceuticals Market Size, 2017-2032 (USD Million)
TABLE 182. Canada Diagnostic Radiopharmaceuticals Market Size, by Imaging Modality, 2017-2032 (USD Million)
TABLE 183. Canada Diagnostic Radiopharmaceuticals Market Size, by Radionuclide, 2017-2032 (USD Million)
TABLE 184. Canada Diagnostic Radiopharmaceuticals Market Size, by Application, 2017-2032 (USD Million)
TABLE 185. Canada Diagnostic Radiopharmaceuticals Market Size, by End Use, 2017-2032 (USD Million)
TABLE 186. France Diagnostic Radiopharmaceuticals Market Size, 2017-2032 (USD Million)
TABLE 187. France Diagnostic Radiopharmaceuticals Market Size, by Imaging Modality, 2017-2032 (USD Million)
TABLE 188. France Diagnostic Radiopharmaceuticals Market Size, by Radionuclide, 2017-2032 (USD Million)
TABLE 189. France Diagnostic Radiopharmaceuticals Market Size, by Application, 2017-2032 (USD Million)
TABLE 190. France Diagnostic Radiopharmaceuticals Market Size, by End Use, 2017-2032 (USD Million)
TABLE 191. Brazil Diagnostic Radiopharmaceuticals Market Size, 2017-2032 (USD Million)
TABLE 192. Brazil Diagnostic Radiopharmaceuticals Market Size, by Imaging Modality, 2017-2032 (USD Million)
TABLE 193. Brazil Diagnostic Radiopharmaceuticals Market Size, by Radionuclide, 2017-2032 (USD Million)
TABLE 194. Brazil Diagnostic Radiopharmaceuticals Market Size, by Application, 2017-2032 (USD Million)
TABLE 195. Brazil Diagnostic Radiopharmaceuticals Market Size, by End Use, 2017-2032 (USD Million)
TABLE 196. Mexico Diagnostic Radiopharmaceuticals Market Size, 2017-2032 (USD Million)
TABLE 197. Mexico Diagnostic Radiopharmaceuticals Market Size, by Imaging Modality, 2017-2032 (USD Million)
TABLE 198. Mexico Diagnostic Radiopharmaceuticals Market Size, by Radionuclide, 2017-2032 (USD Million)
TABLE 199. Mexico Diagnostic Radiopharmaceuticals Market Size, by Application, 2017-2032 (USD Million)
TABLE 200. Mexico Diagnostic Radiopharmaceuticals Market Size, by End Use, 2017-2032 (USD Million)
TABLE 201. Italy Diagnostic Radiopharmaceuticals Market Size, 2017-2032 (USD Million)
TABLE 202. Italy Diagnostic Radiopharmaceuticals Market Size, by Imaging Modality, 2017-2032 (USD Million)
TABLE 203. Italy Diagnostic Radiopharmaceuticals Market Size, by Radionuclide, 2017-2032 (USD Million)
TABLE 204. Italy Diagnostic Radiopharmaceuticals Market Size, by Application, 2017-2032 (USD Million)
TABLE 205. Italy Diagnostic Radiopharmaceuticals Market Size, by End Use, 2017-2032 (USD Million)
TABLE 206. Australia Diagnostic Radiopharmaceuticals Market Size, 2017-2032 (USD Million)
TABLE 207. Australia Diagnostic Radiopharmaceuticals Market Size, by Imaging Modality, 2017-2032 (USD Million)
TABLE 208. Australia Diagnostic Radiopharmaceuticals Market Size, by Radionuclide, 2017-2032 (USD Million)
TABLE 209. Australia Diagnostic Radiopharmaceuticals Market Size, by Application, 2017-2032 (USD Million)
TABLE 210. Australia Diagnostic Radiopharmaceuticals Market Size, by End Use, 2017-2032 (USD Million)
TABLE 211. South Korea Diagnostic Radiopharmaceuticals Market Size, 2017-2032 (USD Million)
TABLE 212. South Korea Diagnostic Radiopharmaceuticals Market Size, by Imaging Modality, 2017-2032 (USD Million)
TABLE 213. South Korea Diagnostic Radiopharmaceuticals Market Size, by Radionuclide, 2017-2032 (USD Million)
TABLE 214. South Korea Diagnostic Radiopharmaceuticals Market Size, by Application, 2017-2032 (USD Million)
TABLE 215. South Korea Diagnostic Radiopharmaceuticals Market Size, by End Use, 2017-2032 (USD Million)
TABLE 216. Russia Diagnostic Radiopharmaceuticals Market Size, 2017-2032 (USD Million)
TABLE 217. Russia Diagnostic Radiopharmaceuticals Market Size, by Imaging Modality, 2017-2032 (USD Million)
TABLE 218. Russia Diagnostic Radiopharmaceuticals Market Size, by Radionuclide, 2017-2032 (USD Million)
TABLE 219. Russia Diagnostic Radiopharmaceuticals Market Size, by Application, 2017-2032 (USD Million)
TABLE 220. Russia Diagnostic Radiopharmaceuticals Market Size, by End Use, 2017-2032 (USD Million)
TABLE 221. Spain Diagnostic Radiopharmaceuticals Market Size, 2017-2032 (USD Million)
TABLE 222. Spain Diagnostic Radiopharmaceuticals Market Size, by Imaging Modality, 2017-2032 (USD Million)
TABLE 223. Spain Diagnostic Radiopharmaceuticals Market Size, by Radionuclide, 2017-2032 (USD Million)
TABLE 224. Spain Diagnostic Radiopharmaceuticals Market Size, by Application, 2017-2032 (USD Million)
TABLE 225. Spain Diagnostic Radiopharmaceuticals Market Size, by End Use, 2017-2032 (USD Million)
TABLE 226. Global Diagnostic Radiopharmaceuticals Market Share, by Key Player, 2025
TABLE 227. Global Diagnostic Radiopharmaceuticals Market, Key Experts

Companies Mentioned

  • Curium MidCo S.à r.l.
  • Lantheus Holdings, Inc.
  • GE HealthCare Technologies Inc.
  • Telix Pharmaceuticals Limited
  • Cardinal Health, Inc.
  • Siemens Healthineers AG
  • Jubilant Pharmova Limited
  • Bracco Imaging S.p.A.
  • China Isotope & Radiation Corporation
  • Novartis AG
  • ABX advanced biochemical compounds GmbH
  • AtomVie Global Radiopharma Inc.
  • Australian Nuclear Science and Technology Organisation
  • BWXT Medical Ltd.
  • Clarity Pharmaceuticals Ltd
  • Curasight A/S
  • Cyclopharm Limited
  • Cyclotek (Aust) Pty Ltd
  • DuChemBIO Co., Ltd.
  • Eckert & Ziegler SE
  • Eli Lilly and Company
  • FutureChem Co., Ltd.
  • Global Medical Solutions, Ltd.
  • Institute of Isotopes Co., Ltd.
  • IRE ELiT S.A.
  • Isologic Innovative Radiopharmaceuticals Inc.
  • ITM Isotope Technologies Munich SE
  • NorthStar Medical Radioisotopes, LLC
  • NTP Radioisotopes SOC Ltd
  • Nucleus RadioPharma, Inc.
  • Nusano, Inc.
  • PDRadiopharma Inc.
  • PharmaLogic Holdings Corp.
  • RadioMedix, Inc.
  • Radiopharm Theranostics Limited
  • ROTOP Pharmaka GmbH
  • SHINE Technologies, LLC
  • SOFIE Co.
  • SpectronRx, Inc.
  • Yantai Dongcheng Pharmaceutical Group Co., Ltd.

Related Topics

Related Reports

Radiopharmaceuticals Market - Global Forecast 2026-2032 - Product Image

Radiopharmaceuticals Market - Global Forecast 2026-2032

  • Report
  • 199 Pages
  • Global
From
SPECT & PET Radiopharmaceuticals Market - Global Forecast 2026-2032 - Product Image

SPECT & PET Radiopharmaceuticals Market - Global Forecast 2026-2032

  • Report
  • 191 Pages
  • Global
From
Radiopharmaceutical Supply Chain Market - Strategic Insights and Forecasts (2026-2031) - Product Image

Radiopharmaceutical Supply Chain Market - Strategic Insights and Forecasts (2026-2031)

  • Report
  • 156 Pages
  • Global
From
Radiopharmaceuticals Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2021-2031 - Product Image

Radiopharmaceuticals Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2021-2031

  • Report
  • 180 Pages
  • Global
From
Radiopharmaceutical CDMO - Market Insights, Competitive Landscape, and Market Forecast - 2034 - Product Image

Radiopharmaceutical CDMO - Market Insights, Competitive Landscape, and Market Forecast - 2034

  • Report
  • 150 Pages
  • Global
From
Copyright © 2002-2026 Research and Markets. All Rights Reserved.